Skip to main content
Scienza Health
Live NowMental/Behavioral Health

ADHD

ADHD screening by GIA®, powered by digitalhumanOS™, uses Voice AI, Computer Vision, and Speech Biomarkers to detect adhd through a single patient conversation. Screening performance: AUC 0.848. Screening takes 40 seconds with results in under 2 minutes.

Unrecognized ADHD impairs focus and concentration, hindering rehabilitation and straining resources.

ADHD can significantly impact patient compliance and progress in post-acute care. Early screening allows for tailored interventions, improving focus and engagement in therapy.

Screening PerformanceAUC 0.848

Key Facts

Screening Time
40 seconds
Results
under 2 minutes
Modalities
Voice + Vision + Speech
Validation
Peer-Reviewed (19 studies)
Status
Live
Peer-ReviewedEditorially reviewed·

This content is intended for informational purposes and does not constitute medical advice. Editorially reviewed by David Kaiser, CEO of Scienza Health, for accuracy in post-acute care operations.

FREQUENTLY ASKED

About ADHD screening.

How does the AI screen for ADHD?

The AI analyzes speech patterns, vocal characteristics, and behavioral cues associated with ADHD.

How will this benefit our patients?

Early identification allows for appropriate accommodations and therapeutic interventions, improving patient focus and engagement.

What is the reported accuracy of your ADHD screening?

Our ADHD screening model has a reported accuracy of 84.8%.

CLINICAL RESEARCH

The science behind ADHD screening.

PEER-REVIEWED RESEARCH

Internal model performance report (v0.2.0, May 2026) from a confidential strategic clinical-validation partner. Reported AUC values (with sensitivity and specificity): depression 0.874 (Sens 0.722, Spec 0.866); anxiety 0.884 (Sens 0.764, Spec 0.850); PTSD 0.907 (Sens 0.888, Spec 0.745); acute stress and nervousness 0.910 (Sens 0.780, Spec 0.891); psychoactive substance use 0.845 (Sens 0.718, Spec 0.806); fatigue and malaise 0.827 (Sens 0.734, Spec 0.910); ADHD 0.848 (Sens 0.634, Spec 0.868); sleep disorders 0.823 (Sens 0.661, Spec 0.831); bipolar disorder 0.726 (Sens 0.444, Spec 0.860). Partner identity withheld per partnership agreement. Operator-confirmed 2026-05-21.

Internal multi-condition model performance report (v0.2.0) (2026-05)

View all peer-reviewed research. See how GIA® screens for ADHD across care settings.

FREE GUIDE

The Operator's Guide to Multimodal Clinical AI

What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.

See What You're Missing.

Schedule a Demo